PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Reveals whether the business's core operations generate sufficient cash to cover expenses, fund growth, and return capital to shareholders. Sustainable free cash flow is often a key indicator of long-term value creation.
-0.91
Negative OCF/share while RVPH has 0.05. Joel Greenblatt would question the viability of operations in comparison.
-0.91
Negative FCF/share while RVPH stands at 0.05. Joel Greenblatt would demand structural changes or cost cuts.
-0.09%
Negative ratio while RVPH is 0.00%. Joel Greenblatt would question whether the firm’s OCF is negative or capex is abnormally large.
1.09
Similar ratio to RVPH's 1.00. Walter Schloss might see both operating with comparable cash conversion.
No Data
No Data available this quarter, please select a different quarter.